Evidence map›Paper›PMID 39156980›Full record

ArticleFarmaceuticos comunitarios2023

[Audit of Antibiotic Dispensing in Community Pharmacy (Happy Patient Project)].

Francisco Javier Plaza Zamora, Ana Mendoza Barbero, Ana Molinero, Navidad Sánchez Marcos, M Lambert, Katja Taxis, Ana García-Sangenis, Carles Llor

Abstract readEnglish Abstract
In one paragraph

Article in Farmaceuticos comunitarios, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francisco Javier Plaza ZamoraFarmacéutico Comunitario en Mazarrón (Murcia). Doctor en Farmacia. Miembro del Grupo de Trabajo de Enfermedades Infecciosas e Inmunología de SEFAC Sociedad Española de Farmacia Clínica, Familiar y Comunitaria España.
Ana Mendoza BarberoFarmacéutica comunitaria en Reus (Tarragona). Miembro del Grupo de trabajo de Respiratorio y tabaquismo de SEFAC Sociedad Española de Farmacia Clínica, Familiar y Comunitaria España.
Ana MolineroFarmacéutica Comunitaria en Fuenlabrada (Madrid). Doctora en Farmacia. Miembro del Grupo de Trabajo de Enfermedades Infecciosas e Inmunología de SEFAC Sociedad Española de Farmacia Clínica, Familiar y Comunitaria España.
Navidad Sánchez MarcosFarmacéutica comunitaria en San Sebastián de los Reyes (Madrid). Miembro del Grupo de trabajo de Respiratorio y tabaquismo de SEFAC Sociedad Española de Farmacia Clínica, Familiar y Comunitaria España.
M LambertUnit of PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, The Netherlands University of Groningen Netherlands.
Katja TaxisUnit of PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands. University of Groningen Netherlands.
Ana García-SangenisFundació Institut Universitari per la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Centro de Investigación Biomédica en Red Enfermedades Infecciosas (CIBERINFEC) Centro de Investigación Biomédica en Red Enfermedades Infecciosas España.
Carles LlorFundació Institut Universitari per la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Centro de Investigación Biomédica en Red Enfermedades Infecciosas (CIBERINFEC) Centro de Investigación Biomédica en Red Enfermedades Infecciosas España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Dispensing and prescribing antibiotics is inappropriate in many of the countries in the European Union, including Spain, and a threat to the population's health. To tackle the growth of antimicrobial resistance, the Happy Patient project was set up under the sponsorship of the European Commission. Aim: O ascertain the characteristics of dispensing antibiotic therapy in Spanish community pharmacies.To compare the variability between different Spanish community pharmacies. Methods: The Audit Project Odense® methodology was used to find out how antibiotics were dispensed in community pharmacies. Pharmacists taking part were asked to record for five consecutive days between the months of February and April 2022 the actions performed during the dispensing of oral antibiotics for human use and for the treatment of acute infections. Results: A total population of 573 patients (59.9% female) of all age groups were interviewed. The patients were 83.6% aware of the purpose for which the antibiotic was prescribed and the most requested antibiotic was amoxicillin followed by amoxicillin with clavulanic acid.In 15% of dispensations, a triple safety check was completed: interactions, contraindications and allergies. The pharmacist rarely contacted the prescriber but when she did, the prescriber altered the prescription.In 62.3% of cases, information about the duration of treatment was provided and amoxicillin with and without clavulanic acid was the antibiotic dispensed for which most warnings about side effects were issued. In 24.6% of dispensations there was no advice given at all. In 81.7% the pharmacist agreed with the prescribed treatment. Conclusions: This audit can be a starting point to improve clinical practice and reduce antibiotic resistance. It highlights the need for safety checks in regard to the use of antimicrobials and suggests verifying dispensing to correct errors that may jeopardize the safety and effectiveness of antimicrobial therapy.

Indexed as

Antibacterial AgentsAntimicrobial StewardshipCommunity Pharmacy ServicesDrug ResistanceMedical AuditPharmacies

Identifiers

PMID39156980
PMCPMC11326684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.